Shifts in the Antibiotic Susceptibility, Serogroups, and Clonal Complexes of in Shanghai, China: A Time Trend Analysis of the Pre-Quinolone and Quinolone Eras
Minggui Wang and colleagues assess the genetic origin and changing prevalence of N. meningitidis resistance to ciprofloxacin.
Vyšlo v časopise:
Shifts in the Antibiotic Susceptibility, Serogroups, and Clonal Complexes of in Shanghai, China: A Time Trend Analysis of the Pre-Quinolone and Quinolone Eras. PLoS Med 12(6): e32767. doi:10.1371/journal.pmed.1001838
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001838
Souhrn
Minggui Wang and colleagues assess the genetic origin and changing prevalence of N. meningitidis resistance to ciprofloxacin.
Zdroje
1. Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C, Durrheim D, Eskola J, et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr. 2013;11:17. doi: 10.1186/1478-7954-11-17 24016339
2. Bratcher HB, Bennett JS, Maiden MC. Evolutionary and genomic insights into meningococcal biology. Future Microbiol. 2012;7:873–885. doi: 10.2217/fmb.12.62 22827308
3. Zalmanovici Trestioreanu A, Fraser A, Gafter-Gvili A, Paul M, Leibovici L. Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev. 2011;10:CD004785.
4. Wu HM, Harcourt BH, Hatcher CP, Wei SC, Novak RT, Wang X, et al. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. N Engl J Med. 2009;360:886–892. doi: 10.1056/NEJMoa0806414 19246360
5. Lapadula G, Vigano F, Fortuna P, Dolara A, Bramati S, Soria A, et al. Imported ciprofloxacin-resistant Neisseria meningitidis. Emerg Infect Dis. 2009;15:1852–1854. doi: 10.3201/eid1511.090833 19891885
6. Skoczynska A, Alonso JM, Taha MK. Ciprofloxacin resistance in Neisseria meningitidis, France. Emerg Infect Dis. 2008;14:1322–1323. doi: 10.3201/eid1408.080040 18680672
7. Singhal S, Purnapatre KP, Kalia V, Dube S, Nair D, Deb M, et al. Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India. Emerg Infect Dis. 2007;13:1614–1616. doi: 10.3201/eid1310.060820 18258023
8. Tzanakaki G, Blackwell CC, Kremastinou J, Kallergi C, Kouppari G, Weir DM. Antibiotic sensitivities of Neisseria meningitidis isolates from patients and carriers in Greece. Epidemiol Infect. 1992;108:449–455. 1601078
9. Hong E, Hedberg ST, Abad R, Fazio C, Enriquez R, Deghmane AE, et al. Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin. Antimicrob Agents Chemother. 2013;57:1961–1964. doi: 10.1128/AAC.02184-12 23357770
10. Chu YW, Cheung TK, Tung V, Tiu F, Lo J, Lam R, et al. A blood isolate of Neisseria meningitidis showing reduced susceptibility to quinolones in Hong Kong. Int J Antimicrob Agents. 2007;30:94–95. 17408928
11. Corso A, Faccone D, Miranda M, Rodriguez M, Regueira M, Carranza C, et al. Emergence of Neisseria meningitidis with decreased susceptibility to ciprofloxacin in Argentina. J Antimicrob Chemother. 2005;55:596–597. 15728148
12. Wang JF, Caugant DA, Li X, Hu X, Poolman JT, Crowe BA, et al. Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People’s Republic of China. Infect Immun. 1992;60:5267–5282. 1452360
13. Li J, Li Y, Yin Z, Yang J, Shao Z, Ning X, et al. [Epidemiological analysis of the meningococcal disease in China During 1997–2006.] China J Vaccine Immun. 2007;13:453–456.
14. Shao Z, Li W, Ren J, Liang X, Xu L, Diao B, et al. Identification of a new Neisseria meningitidis serogroup C clone from Anhui province, China. Lancet. 2006;367:419–423. 16458767
15. Zhou H, Liu W, Xu L, Deng L, Deng Q, Zhuo J, et al. Spread of Neisseria meningitidis serogroup W clone, China. Emerg Infect Dis. 2013;19:1496–1499. doi: 10.3201/eid1909.130160 23965378
16. Fagan M, Maehlen M, Lindbaek M, Berild D. Antibiotic prescribing in nursing homes in an area with low prevalence of antibiotic resistance: compliance with national guidelines. Scand J Prim Health Care. 2012;30:10–15. doi: 10.3109/02813432.2011.629156 22188479
17. Taur Y, Smith MA. Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection. Clin Infect Dis. 2007;44:769–774. 17304445
18. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32:331–351. 11170940
19. Wood J, Butler CC, Hood K, Kelly MJ, Verheij T, Little P, et al. Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines. Eur Respir J. 2011;38:112–118. doi: 10.1183/09031936.00145810 21233267
20. Hanlon JT, Aspinall SL, Semla TP, Weisbord SD, Fried LF, Good CB. et al. Consensus guidelines for oral dosing of primarily renally cleared medications in older adults. J Am Geriatr Soc. 2009;57:335–340. doi: 10.1111/j.1532-5415.2008.02098.x 19170784
21. Wang F, Zhu D, Wang Y. Surveillance of bacterial resistance to quinolones. Drugs. 1993;45:170–171.
22. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14:742–750. doi: 10.1016/S1473-3099(14)70780-7 25022435
23. Hu S, Zhang W, Li F, Hu Z, Ma E, Zheng T, et al. Neisseria meningitidis serogroup W135 sequence type 11, Anhui Province, China, 2011–2013. Emerg Infect Dis. 2014;20:1236–1238. doi: 10.3201/eid2007.131138 24960586
24. Song L, Ning Y, Shen J, Fan X, Zhang C. Investigation of resistance of animal Escherichia coli from food in different periods of China. Sci China Life Sci. 2009;39:692–698
25. Zhu H, Wang Q, Wen L, Xu J, Shao Z, Chen M, et al. Development of a multiplex PCR assay for detection and genogrouping of Neisseria meningitidis. J Clin Microbiol. 2012;50:46–51. doi: 10.1128/JCM.00918-11 22090406
26. Mothershed EA, Sacchi CT, Whitney AM, Barnett GA, Ajello GW, Schmink S, et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol. 2004;42:320–328. 14715772
27. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. M100-S23. Wayne (Pennsylvania): Clinical and Laboratory Standards Institute; 2013.
28. Birtles A, Hardy K, Gray SJ, Handford S, Kaczmarski EB, Edwards-Jones V, et al. Multilocus sequence typing of Neisseria meningitidis directly from clinical samples and application of the method to the investigation of meningococcal disease case clusters. J Clin Microbiol. 2005;43:6007–6014. 16333090
29. PubMLST. Neisseria sequence typing home page. Available: http://pubmlst.org/neisseria/. Accessed October 21, 2014.
30. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol. 2004;186:1518–1530. 14973027
31. Popovic T, Schmink S, Rosenstein NA, Ajello GW, Reeves MW, Plikaytis B, et al. Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol. 2001;39:75–85. 11136752
32. Stefanelli P, Fazio C, La Rosa G, Marianelli C, Muscillo M, Mastrantonio P. Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. J Antimicrob Chemother. 2001;47:219–222. 11157912
33. Li W, Lu S, Cui Z, Cui J, Zhou H, Wang Y, et al. PulseNet China, a model for future laboratory-based bacterial infectious disease surveillance in China. Front Med. 2012;6:366–375. doi: 10.1007/s11684-012-0214-6 23124882
34. Peng J, Yang L, Yang F, Yang J, Yan Y, Nie H, et al. Characterization of ST-4821 complex, a unique Neisseria meningitidis clone. Genomics. 2008;91:78–87. 18031983
35. Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, version 3.01a. Available: http://www.OpenEpi.com. Accessed September 22, 2014.
36. Brandtzaeg P. Classification of the clinical presentations. In: Frosch M, Maiden MCJ, editors. Handbook of meningococcal disease: infection biology, vaccination, clinical management. Weinheim: Wiley; 2006. pp. 427–480.
37. du Plessis M, de Gouveia L, Skosana H, Thomas J, Blumberg L, Klugman KP, et al. Invasive Neisseria meningitidis with decreased susceptibility to fluoroquinolones in South Africa, 2009. J Antimicrob Chemother. 2010;65:2258–2260. doi: 10.1093/jac/dkq291 20688769
38. Zhu B, Fan Y, Xu Z, Xu L, Du P, Gao Y, et al. Genetic diversity and clonal characteristics of ciprofloxacin-resistant meningococcal strains in China. J Med Microbiol. 2014;63:1411–1418. doi: 10.1099/jmm.0.078600-0 25082942
39. Li F. [Immunoprophylaxis of epidemic meningococcal meningitis.] In: Zuo W, Diao L, Xu A, editors. [Scheduled immunology.] Shanghai: Shanghai Scientific and Technological Literature Press; 2010. pp. 470–471.
40. Zhou H, Gao Y, Xu L, Li M, Li Q, Li Y, et al. Distribution of serogroups and sequence types in disease-associated and carrier strains of Neisseria meningitidis isolated in China between 2003 and 2008. Epidemiol Infect. 2012;140:1296–1303. doi: 10.1017/S0950268811001865 21929839
41. du Plessis M, Wolter N, Crowther-Gibson P, Hamstra HJ, Schipper K, Moodley C, et al. Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adults. J Infect. 2014;68:455–461. doi: 10.1016/j.jinf.2013.12.011 24393652
42. Daugla DM, Gami JP, Gamougam K, Naibei N, Mbainadji L, Narbe M, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. Lancet. 2014;383:40–47. doi: 10.1016/S0140-6736(13)61612-8 24035220
43. Jin Y, Wang X, Hu Z, Wang H. [Analysis on the epidemic situation of cerebro-spinal meningitis and its prevention and control measures in 2004 in Hefei City.] Anhui J Prev Med. 2006;12:218–222.
44. Zhang F, He Y, Sheng W. [Investigation of the first case of meningococcal meningitis W135 in Tongling, Anhui.] Dis Surveill. 2012;27:923–924.
45. Girgis N, Sultan Y, Frenck RW Jr, El-Gendy A, Farid Z, Mateczun A. Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. Pediatr Infect Dis J. 1998;17:816–819. 9779768
46. Zhu P, van der Ende A, Falush D, Brieske N, Morelli G, Linz B, et al. Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc Natl Acad Sci U S A. 2001;98:5234–5239. 11287631
47. Li Y, Zeng M, Wang X, Wang D. [Clinical epidemiology of epidemic cerebrospinal meningitis in children in Shanghai area from 1984 to 2003.] Chin J Infect Chemother. 2004;4:321–323.
48. Hall BG. Building phylogenetic trees from molecular data with MEGA. Mol Biol Evol. 2013;30:1229–1235. doi: 10.1093/molbev/mst012 23486614
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2015 Číslo 6
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- The Mistreatment of Women during Childbirth in Health Facilities Globally: A Mixed-Methods Systematic Review
- The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries
- Mistreatment of Women in Childbirth: Time for Action on This Important Dimension of Violence against Women
- Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study